Topic: Reply to Colleague Matthew Q AshCL7WK5D1-1
Style | APA |
Number of words | 391 |
Number of sources | 2 |
Spacing | Double |
PowerPoint slides | 0 |
Details: Please read Colleague Matthew Q’s post to week 5 discussion 1. (Colleague Matthew Q’s post to week 5 discussion 1 is attached). Please provide a response to Matthew Q’s post to week 5 discussion 1 answering the following questions.
What was the substance of your colleague’s argument? Do you agree with this argument? Why, or why not? To what extent did your colleague consider the ethical dimension to this risk-benefit calculation when prescribing drugs for children who are too young to be of the age of legal consent? Whether you agree or disagree with the conclusion, was the ethical aspect dealt with in a responsible manner? What insights did your colleague include that you had not considered? What might you suggest he or she consider which was not already included? Please use your research to support your assertions.